Sage Therapeutics
SAGE
#7026
Rank
A$0.81 B
Marketcap
A$13.05
Share price
0.00%
Change (1 day)
3.89%
Change (1 year)

Earnings for Sage Therapeutics (SAGE)

Earnings in 2025 (TTM): -A$0.47 Billion

According to Sage Therapeutics 's latest financial reports the company's current earnings are A$70.41 Million. In 2024 the company made an earning of -A$0.61 Billion, an increase over its 2023 earnings that were of -A$0.82 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sage Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.47 Billion-22.92%
2024 -A$0.61 Billion-26.01%
2023 -A$0.82 Billion1.63%
2022 -A$0.81 Billion16.36%
2021 -A$0.69 Billion-175.55%
2020 A$0.91 B-189.1%
2019 -A$1.03 Billion82.43%
2018 -A$0.57 Billion38.04%
2017 -A$0.41 Billion69.9%
2016 -A$0.24 Billion68.25%
2015 -A$0.15 Billion179.48%
2014 -A$50.85 Million84.98%
2013 -A$27.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-A$71.33 Million-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
A$53.62 M-111.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
A$0.77 B-270.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-A$87.24 Million-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA